Audrey DERVELOY

President & Country Lead, Sanofi France
Since September 2022, Audrey Derveloy coordinates all the Sanofi's activities in France and represents the company to its various stakeholders. She leads the Sanofi France Strategic Committee and the Country Council.
She sits on the Board of Directors of Leem (Les Entreprises du Médicament) and chairs the French Federation of Health Industries (FEFIS) and the Comité Stratégique de Filière - Industries et technologies de santé.
Physician by training, Audrey Derveloy started her career in public hospitals in Paris. She then moved on as Researcher at the Pasteur Research Center of the Hong Kong University and later as a Scientific Expert at Salusmed, also in Hong Kong. She came back to France joining Pfizer working in medical affairs in the areas of Endocrinology, Transplant and Rheumatology. She later joined Novartis in France where she progressively grew in her career leading her to be appointed Business Franchise Head for Ophthalmology.
Since January 2020, she was President of Novartis in Ireland. During this period, she was a member of the strategic council of the IPHA (Irish Pharmaceutical Healthcare Association) and French Foreign Trade Advisor.
Audrey Derveloy is a Medical Doctor by the Faculté de Médecine de Paris 5 - Cochin and a DES in Medical Biology.